Diarrhoeal disease is Kenya’s third leading cause of pediatric deaths after malaria and pneumonia [1]. According to UNICEF 2022, diarrhoeal diseases account for an estimated 1300 deaths per day in children below five years of age [2]. This burden is higher in informal settlements, characterized by insufficient toilet facilities, inadequate sewage drainage infrastructure, overcrowding, and poor sanitation practices. It is estimated that 48% of Kenya’s population lacks access to safe water and has limited sanitation amenities, resulting in improper disposal of fecal waste in the informal settlements [3, 4].

Although parasites and viruses have been associated with diarrhea diseases, bacteria are the most common aetiological agents, especially Escherichia coli, Clostridium botulinum, Shigella, Staphylococcus aureus, Campylobacter jejuni, Vibrio cholera, and Salmonella [5]. Children aged 5 years and below are at higher risk of foodborne bacterial infections caused by Campylobacter jejuni, Vibrio cholerae, E.coli, Salmonella,andShigellaspecies[6]. Approximately, Shigella causes about 125 million diarrhea episodes and 160,000 deaths every years, with a third are related to young children [7], while diarrheagenic E.coli causes 70,000 deaths in children under 5 years of age in Africa [8]. These bacteria are ingested along with unsafe food and water. They can also be contracted by touching animals suffering from diarrhea, polluted environments, or contact with a person’s stool. Acute diarrhea caused by these bacteria is often characterized by a massive loss of water that forms a large proportion of children’s body weight, leading to rapid dehydration that can lead to death. The severity of acute water loss is aggravated by children using more water daily due to their higher metabolic rates than adults [9].

The primary care for diarrhea involves the replacement of lost electrolytes and water through oral rehydration solution (ORS) [10]. The World Health Organization does not recommend antibiotic treatment of diarrhea in children, but traveler’s diarrhea, commonly associated with enterotoxigenic and enteroaggregative E. coli, non-typhoidal Salmonella, and Shigella spp, requires proper antibiotic therapy to shorten the bacterial excretion and manage the clinical symptoms [11, 12]. In our Kenyan settings, antibiotic treatment of diarrhea involves using oral metronidazole, azithromycin, ciprofloxacin, and amoxiclav [13]. The parenteral antibiotic intervention involves the use of ceftriaxone or ciprofloxacin injections [14] The continued use and misuse of these antimicrobials has resulted in high levels of resistance against commonly available antimicrobials. These enteric bacteria interact within the gut with the potential to transmit and exchange resistance genes, leading to the emergence of multidrug-resistant strains [15]. Diarrhea caused by multidrug-resistant bacteria can result in longer hospitalization, poor treatment outcomes, and increased mortality [16]. Despite drug-resistant enteric bacteria being a significant cause of children’s morbidity and mortality, the full extent of the burden of disease is not well known. This study sought to investigate the common enteric bacterial agents associated with childhood diarrhea and their corresponding antibiotic susceptibility patterns.


Study design and site

A cross-sectional study design was employed to conduct the study between May 2021 and November 2021 in Mukuru informal settlement, the second-largest informal set-up in Kenya,. The participants were purposively recruited from outpatient clinics located in this informal settlement, in Municipal City Council (MCC), Mukuru kwa Reuben (MR), Medical Missionaries of Mary (MMM), and Mama Lucy Kibaki Hospital (MLKH) Nairobi, the referral facility for patients from MCC, MR, and MMM. MCC, MMM, and MR are level 1/ 2 facilities and thus do not have inpatient facilities, while MLKH operates as an outpatient and inpatient hospital with a 135-bed capacity and a 35-bed children’s ward on the ground floor of the inpatient wing. The ward is divided into an acute care and chronic care unit managing various medical conditions in children aged 1 month to 12 years of age. The clinics were selected because they have the capacity to handle over 1000 cases of diarrheal infections per month, they offer affordable services like a child welfare clinic, and the fact that the research team has long-standing professional relationships with the management of these hospitals.

Study recruitment

A healthcare worker at each of the clinics identified patients presenting mainly with abdominal pain and intense and frequent urge for bowel movement, accompanied by other symptoms including vomiting, fever, dehydration, weight loss, and loose stool. Participants who had taken antibiotics within the previous 7 days to treat other illnesses were excluded from the study, as confirmed by the clinician and the guardian/parent of the child. The parents/guardians of the participants meeting the inclusion criteria were interviewed to obtain the history of their illness and then asked to provide a stool sample or a rectal swab. However, we did not recruit inpatient children and those who were being given parenteral antibiotics.


According to the Kenya Bureau of Statistics 2019 census data, 11.2% of Kenya’s population is between 0 and 4 years of age. Using these statistics, we estimated that from a total population of 150,000 people in Mukuru kwa Reuben and Njenga, 16, 800 of its population is below the age of 5 years ( A purposive sampling method (children presenting exclusively with diarrhea were recruited) was used to calculate the working sampling size from our target population of.

16, 800 children. Fisher’s sample size calculation method was used to establish the sample.

size in the study [17].

N = Z 2 P (l-P)/d 2.

Where N = Minimal sample size:

Z = Standard normal deviation corresponding to 95% confidence interval (= 1.96);

P = Estimated prevalence of diarrhoea in children under 5 in Kenya, which in this case is 15% [18].

d = degree of precision (5%).

= (1.96) 2 0.15(1-0.15)/ (0.05) 2 = 195.9216

N = 196 minimum fecal samples.

219 Stool samples per recruitment site were collected depending on how many children presented mainly with diarrhea and had met our inclusion criteria during the participants recruitment period.

Stool sample collection

The fecal sample was collected in a poly pot by the guardian or the parent following guidance from the attending nurse. For children over two years, a cotton rectal swab was used and moistened to avoid discomfort to the child. The collected stool samples were labeled with unique identifiers, kept in Cary Blair transport media, transported to the Centre for Microbiology laboratory in a cool box, and processed within 24 h.

Bacterial isolation and identification

Direct plating on MacConkey agar (Oxoid) and Salmonella Shigella agar (Oxoid)media was done in the lab. Enrichment was also done on Selenite Faecal broth(Oxoid) to optimize the recovery of Salmonella and incubated at 37 ℃ overnight [19]. The non-duplicate enteric colonies were identified using colony morphology, Gram staining, VITEK 2 system (bioMérieux), and PCR [20]. The following NTCT and ATCC organisms were used as positive controls for the detection of the enteric pathogens: NCTC 13,420 to help in the identification of Acinetobacter baumannii, NCTC 10,975 to identify Proteus mirabilis, NCTC 12,028 to identify Morganella morganii, NCTC 8900 to identify Serratia marcescens, E.coli ATCC 25,922 and S. aureus ATCC 25,923. For the recovered E. coli isolates, PCRs were done to identify pathotypes of E.coli associated with opportunistic pediatric diarrhea. The targeted genes for intestinal E. coli pathotypes included bundle-forming pilus(bfpA) of enteropathogenic E.coli (EPEC), Shiga toxin (stx1) of enterohemorrhagic E.coli (EHEC), transcriptional activator (aggR) of enteroaggregative E.coli (EAEC), heat-labile toxin (LT) of enterotoxigenic E.coli (ETEC), heat-stable toxin (sth) of ETEC, stp of ETEC, and afimbrial adhesins(afa) of diffusely adherent E.coli (DAEC) [21]. All E. coli isolates and commercially bought positive controls for each of the genes tested had their DNA extracted using the boiling method previously described by [22]. Briefly, a loopful of pure culture was emulsified in 1 ml distilled DNase/RNase-free water and boiled at 95 °C for 12 min in a heating block. Centrifuging for 5 min at 14 000 rotations per minute did the separation of bacterial cell debris and DNA. The extracted DNA’s quality and concentration were measured using 1% gel electrophoresis stained using SYBR green [23]. The DNA templates were amplified using specific oligonucleotide primer pairs, Table 1. Qiagen master mix was used, where the final volume was 25 µL in a master mix containing one µl forward primer(0.2µM), one µl reverse primer (0.2µM),11 µl PCR water,11 µl PCR mix (QIAGEN, Germany) with the PCR components such as; Taq DNA Polymerase(2.5units), PCR Buffer(1x), MgCl2 (0.2µM), and ultrapure dNTPs(200µM),) followed by addition of 1 µl template DNA. DNA amplification was performed using the following thermal profile for 35 cycles: initial denaturation for 5 min at 95 ℃, followed by final denaturation for 30 s at 94 ℃, variable annealing (shown in Table 1) for 1 min, initial extension for 2 min 30 s at 72 ℃ followed by final extension for 7 min at 72 ℃. 10 µl of amplicons were analyzed by electrophoresis on 1.5% agarose gel. The sizes of the amplicons were determined by comparing them with a 100 bp DNA ladder.

Table 1 Escherichia coli pathotypes genes analyzed, and the primers used

Antimicrobial susceptibility testing

Antibiotic susceptibility testing for 157 non-duplicate representative isolates of each genus was done using the VITEK 2®AST-GN83card on VITEK 2® automated platform. The minimum inhibitory concentration (MIC) interpretations were done using Clinical and Laboratory Standards Institute (CLSI 2022) and the VITEK 2 ® Advanced Expert System(AES), and the analysis using WHONET software followed. The following antimicrobial agents were tested: ampicillin (AMP), amoxicillin/clavulanic acid (AMC), ampicillin/ Sulbactam (SAM), piperacillin/tazobactam (TZP), cefazolin (CZO), cefuroxime(CXM), cefuroxime axetil (CXA), cefoxitin (FOX), cefotaxime (CTX), ceftazidime (CAZ), ceftriaxone(CRO), cefepime(FEP), aztreonam(ATM), meropenem (MEM), amikacin (AMK), gentamicin (GEN), ciprofloxacin (CIP, nitrofurantoin (NIT), and trimethoprim-sulfamethoxazole (SXT). The MICs generated were used to cluster the isolates into various resistance profiles ranging from fully sensitive, intermediate, and resistant. Isolates exhibiting resistance to 3 or more classes or subclasses of antibiotics were scored as Multidrug-resistant (MDR) as defined by the European Center for Disease Control (ECDC) [24], while those that were resistant to penicillins, 1st,2nd, 3rd cephalosporins and aztreonam were scored as ESBLs(Extended Spectrum Beta-lactamase). Isolates, both intermediate and resistant to meropenem, were scored as carbapenemases, while isolates with combined resistance to β-lactams, fluoroquinolone, and aminoglycosides such as gentamicin were denoted as βFQA-strains [24].

Data analysis

Data was analyzed using the Statistical Package for Social Sciences (SPSS), version 20. Descriptive analysis was used to show the distribution of recovered bacterial enteric per recruitment site, gender, and age group. Antimicrobial-resistant patterns were interpreted and analysed using the M 100 Clinical and Laboratory Standards Institute (CLSI 2022) and the VITEK 2® Advanced Expert System (AES). And the Antimicrobial resistant patters were analyzed using WHONET 2023 Moreover the statistical significance of distribution of recovered bacteria isolates between gender, age group and recruitment site was done using Fisher’s exact test.


Patients’ demographic characteristics

Of the 219 participants recruited, 117(53%) were male. The participants in age category 12–24 were significantly higher than other age categories, p < 0.001, as shown in Table 2.

Table 2 demographic characteristics of the patients recruited in four recruitment sites

Bacterial isolation

At least one bacterial organism was recovered from 213 (97%) participants, with 115(56%) participants having only one bacterial type isolated and 43.2% (92/213) polyculture, with 90(43%) with two types of bacteria recovered and the common combination being Enterobacter cloacae and E.coli, and 2(1%) with three types of bacteria recovered (Shigella, Proteus mirabilis and Enterobacter cloacae combination while the other combination being Salmonella, Proteus mirabilis and Klebsiella Pnuemoniae). The most predominant bacteria recovered was 85%(93/109) non-pathogenic E.coli and 15% (16/109)of pathogenic E.coli, with 2 (1%) were Enterohemorrhagic E.coli (EHEC), 6 (3%) were Enteroaggregative E.coli (EAEC), and 8 (4%) were Enteropathogenic E.coli(EPEC). Other potentially pathogenic bacteria included Enterobacter sp (27.8%), Klebsiella sp 33(11%), and Citrobacter sp 15(4.7%), with specific species of each genus shown in Fig. 1. Other pathogenic isolates such as Salmonella spp 7 (2%), Proteus mirabilis 16 (6%), Providencia alcalifaciens 1 (0.3%), and Shigella spp 16 (4.7%) were also isolated. Rarely reported but implicated with opportunistic diarrhoeal disease diseases isolates such as Pantoea spp 2 (0.67%), Raoultella planticola 1(0.33%), and Kluyvera spp 5 (2) were also recovered, as depicted in Fig. 1 below.

Fig. 1
figure 1

percentage proportion of bacterial enterics isolated. (n) represents the number of enterics recovered. Enteropathogenic E.coli (EPEC), Enterohemorrhagic E.coli (EHEC), and Enteroaggregative E.coli (EAEC)

Antibiotic resistance patterns

Overall, ampicillin (AMP), sulfamethoxazole-trimethoprim (STX), and cefazolin (CZO) were the least effective antimicrobials, with resistance at 64%, 54% & 51%, respectively. Similarly, relatively high resistance towards cefoxitin (33%) and ampicillin-sulbactam (31%) was also recorded. Meropenem, amikacin, tazobactam piperacillin, and cefepime were the most effective, with less than 5% resistance. For antibiotics commonly used for the treatment of diarrhea resistance levels were; amoxiclav (31%), ceftriaxone (14%), and ciprofloxacin (11%), Fig. 2. The resistance levels towards ceftazidime, ceftriaxone, and cefepime range between 5 and 14%. Among antibiotic-inhibitor combinations, amoxicillin-clavulanic acid and ampicillin-sulbactam resistance were at 31%, while for tazobactam piperacillin resistance was (4%).

Genus-specific analysis showed that E coli isolates were resistant to at least 1 of the 20 antibiotics tested, and two (3.6%) non-pathogenic E. coli isolates were resistant to meropenem, as shown in Table 3. E.coli, Enterobacter spp & Klebsiella spp were the most resistant to broad-spectrum antimicrobials such as ceftazidime, ceftriaxone ciprofloxacin, gentamicin, and cefepime, ranging between 6 and 33%. Resistance to all 20 antibiotics was high in the age group 12–24 months, while isolates from participants 0–11 months were the least resistant. Notably, meropenem resistance in the non-pathogenic E.coli was recorded in two recruitment sites, MMM and MCC. Gentamicin resistance was noted in isolates recovered from the MMM (7.4%), MCC (14.3%), and MR (15%) and not in the referral hospital MLK, while amikacin resistance was only recorded in MLK (4.8%) hospital. The isolates recovered as polyculture slightly differed in antibiotic susceptibility patterns for all tested antibiotics. For instance, one patient had Klebsiella pneumoniae, and E.coli recovered from their stool. Their ASTs patterns differed, where Klebsiella pneumoniae was fully susceptible to aztreonam, cefepime, and piperacillin-tazobactam, but E.coli showed resistance ranging between 1 and 6%.

Table 3 Antimicrobial resistance profile across the genera of the recovered bacterial enterics. (n) represents the number of bacteria enterics resistant to the antimicrobial

A total of 33(21%) bacterial isolates were multidrug-resistant (MDR) organisms resistant to three or more classes of antibiotics, with the most common MDR phenotype being a combination of ampicillin, amoxiclav, ampicillin-sulbactam, aztreonam, cefazolin, and sulfamethoxazole-trimethoprim at 13%. Of the 33 MDR isolates, 26 (78.8%) were E.coli, with 2 EPEC and 1 EAEC, 2(6%) were Klebsiella pneumoniae, 1(3%) were Klebsiella oxytoca, 1(3%) Proteus mirabillis,1(3%) Kluyvera cryoscrescence and 2(6%) was Enterobacter cloacae. Moreover, 3(1.9%) non-pathogenic E.coli, each from MMM, MCC, and MR, were extensively drug-resistant (XDR) to 6/7 classes of antibiotics tested. A total of 22(14%) were Expanded Spectrum Beta Lactamase (ESBL) producers, presented by 18 E.coli, 1 Klebsiella oxytoca, 1 Klebsiella pneumoniae, 1 Kluyvera cryoscrescence and 1 Enterobacter cloacae from all the recruitment sites, while 2(1%) non-pathogenic E.coli were carbapenemase producers from MMM and MLK, and 8(5%),7 E.coli and1 Klebsiella pneumoniae from the 4 hospitals had Beta-lactam, Fluoro/Quinolones, Aminoglycosides(BFQA) resistance phenotype, as shown in Fig. 3.

Fig. 2
figure 2

Antibiotic-resistant patterns (%) for the recovered bacteria enterics. (n/157) represents the number of bacteria enterics resistant to the antimicrobials out of 157 bacteria subjected to AST. * ampicillin and ampicillin sulbactam resistance were out 100 and 99, respectively, since the Vitek 2 VITEK 2® automated platform did not test it against organisms with intrinsic resistance, including Citrobacter freundii, Enterobacter cloacae, Enterobacter aerogenes, and Morganella morganii

Fig. 3
figure 3

Important resistance alerts portrayed by the recovered bacterial enterics. () represents the actual number of isolates. MDR- multidrug-resistant isolates, ESBL-expanded spectrum beta lactamases, XPD/XDR-Extensively drug-resistant isolates, BFQA- Beta-lactam, Fluoro/Quinolones, Aminoglycosides


The recovery of at least one bacterial enteric from 213/219(97%) implies bacterial etiologies are a significant cause of diarrhea illnesses in children under five years. 43.2% (92/213) of participants were polyculture, with the recovery of the normal intestinal flora alongside pathogenic bacteria enterics associated with childhood diarrhea. The most dominant pathogenic E.coli isolation rate at 15% % (16/109), with 1% EHEC, 4% EPEC, and 3% EAEC, confirms E.coli as a leading cause of diarrhea in under-five years child in Mukuru. Our finding differed from the Zelelie et al. study conducted in Ethiopia among children under five years of age with acute diarrhea and hospitalized or visited the institutions as an outpatient, where the EPEC isolation rate was 13%, 6% EHEC, and 6% EAEC [25]. Moreover, this study’s findings contrast Webale et al. (2020) study conducted in children under five years visiting Mbagathi Hospital, where 36.4% wre pathogenic E.coli, with 20.9% EAEC, 10.2% Enterotoxigenic E.coli (ETEC), 4% EPEC, and 0.5% Enteroinvasive E.coli (EIEC) [26]. Similarly, a study by Impwi et al. (2016) carried out in Mukuru informal settlement in diarrheagenic children under five years had a different isolation rate of E.coli, where 27.1% was EAEC, 37.4% EPEC, 27.1% ETEC, 4.2% EHEC,and 4.2% EIEC [27].In the neighboring Uganda, the isolation rate of EPEC was 6.7%, 14.2% EAC, and 3% EAEC, from a study conducted among inpatient children under 5 years [28], disagreeing with our findings. The varying results across different geographical locations and regions could imply pathogenic E.coli burden varies with locations. The variations could also have been attributed to different inclusion criteria in the study, for instance, Zelelie et al.’s study recruited children who were interacting with calves, while the study conducted in Uganda had inpatient children only. This suggests a need for standardized testing worldwide for diarrhea in children for better surveillance and comparison in the future.

The study also identified rarely reported isolates but implicated with diarrhea diseases such as Pantoea spp, Raoultella planticola, and Kluyvera, while other previous studies in Kenya did not [15, 17, 29]. The current study used VITEK 2®system (bioMérieux) for comprehensive bacterial identification, while these previous studies used the basic biochemical and serotyping methods, signifying a more sensitive automated identification method is superior and should be adopted for robust identification and better treatment plans. Our findings had a lower Pantoea spp isolate rate than a cross-sectional study conducted in two Nigerian healthcare centers among infants with 3.85% [30]. The Raoultella planticola isolation rate in the current study was lower than Afum’s and colleagues’ cross-sectional study conducted among diarrheagenic patients in Ghana, with a 2% isolaion rate [31]. The variations in the isolation rate could be attributed to the burden varying with locations.

The study identified Enterobacter spp as the second dominant bacterial enterics. Among them, Enterobacter cloacae was the most dominant(24.5%). These findings differ from previous studies, which identified Shigella spp as the second most dominant [26, 27, 29]. Usually, Enterobacter cloacae, together with Citrobacter freundii, Enterobacter cloacae complex, Enterobacter aerogenes, and Morganella morganii, are a gut-normal flora that becomes pathogenic when the bacterial load increases, and they acquire virulence genes from other pathogenic isolates. Our study, however, had a 5.2% Shigella isolation rate, a lower rate than 83.8% from a study conducted in Kenya during two different climatic seasons [32]. The differences in the isolation rates could imply changes in trends of bacteria associated with childhood diarrhea. Other possibilities could be related to the study’s comprehensive identification system, recruitment of patients with only acute bloody diarrhea, and climatic seasons aspects in the inclusion criteria.

The study recovered Proteus mirabilis among the bacterial associated with diarrhoea in children under five years. The isolation rate(5.2%) was inconsistent with a 14.5% rate from a study conducted in the same informal settlement four years ago from the day of sample collection [27]. These findings agree with a study conducted in Accra, Ghana, where Proteus mirabilis was isolated at 5.7%, slightly higher than our study’s rate of 5.2% [33]Thse findings imply that Proteus mirabilis is a common cause of childhood diarrhea, which also agrees with findings from Yu et al. (2015). The isolation rate of Salmonella spp (2.3%) agreed with the 2.4% isolation rate from similar studies in Mbagathi Hospital [26].. However, this increased from 1.5% in 2016 [26], suggesting changes in patterns of bacteria in circulation in the informal settlement.

A significant proportion of the recovered bacterial enterics were resistant to commonly used antibiotics to manage diarrhea. There was 64% resistance to ampicillin, 55% to sulfamethoxazole-trimethoprim, and 57% to cefazolin. It is important to note that some of the recovered bacteria, such as Citrobacter freundii, Enterobacter cloacae, Enterobacter aerogenes, and Morganella morganii, contain intrinsic resistance to ampicillin [34] hence the VITEK 2®system (bioMérieux) did not test for it. The high resistance to AMP, SXT (Septrin ™), and CZO could be attributed to the fact that they are readily available in informal settings as over-the-counter drugs [35]. Our findings are consistent with Impwi et al. (2016), which documented high resistance to ampicillin and sulfamethoxazole-trimethoprim [27]. This implies that the resistance levels have been constant in these settings, and there should be a change in treatment options available for better management of bacterial infections.

Additionally, the study documented a 33% resistance toward cefoxitin, differing from Impwi et al. (2016) study conducted in the Mukuru informal settlement, showing a 64% resistance [27]. This variation could have resulted from the recruitment differences where Impwi and colleagues recruited children under five without diarrhea while our study recruited diarrheagenic pediatrics. Moreover, the four-year difference could have allowed for more antimicrobial stewardship in the settings. The high-level resistance to cefoxitin could be associated with the intrinsic resistance of some of the recovered enterics, such as Citrobacter freundii, Enterobacter cloacae, and Enterobacter aerogenes [34].

There was 1% carbapenem resistance for non-pathogenic E.coli. These findings are slightly lower than Dela et al. (2022) findings that documented a 4% meropenem resistance by E.coli recovered from diarrheagenic patients in Accra, Ghana [36]. Although the differences in the recruitment criteria and the testing methods applied in the studies could have accounted for the variations in resistance, the results imply that resistance varies across geographical locations and regions. The findings are worrying as commensal E. coli is harboring carbapenem resistance, and horizontal gene transfer can spread resistance to other pathogenic microorganisms, resulting in severe bacterial infections with reduced treatment options. Additionally, resistance to aminoglycosides would signify differences in antibiotics used in hospitals, as amikacin is majorly given as an injection, and this could imply that resistance recorded in MLKH, a referral hospital, uses it. Also, co-resistance between beta-lactams, fluoro/quinolones, and aminoglycosides suggests limited treatment options for childhood diarrhoea, with severe consequences, including increased mortality rates.

Study limitations

The data was collected from children that had visited the clinics to seek treatments for diarrhoea; therefore, a true community prevalence of diarrhoea in children in the Mukuru informal settlement could not be reflected. However, these groups form an important part that can be used to extrapolate what happens in the community, as they are commonly treated with readily available antibiotics. The study was also conducted immediately after the COVID-19 lockdowns, which limited the sample size as people were still hesitant to visit the hospitals. Due to logistical constraints, only 157 samples were subjected to Antimicrobial Susceptibility Testing, and only E.coli isolates had their pathogenicity confirmed.


The study documented different bacteria implicated as aetiologies of childhood diarrhoea that were not limited to E.coli, Shigella, and Salmonella, as previously observed in Kenya. The presence of Meropenem-resistant non-pathogenic E.coli suggests the possible emergence of carbapenem-resistant strains in the Mukuru informal settlement. Recovery of MDR strains suggests emerging limited treatment options for childhood diarrhoea, with severe consequences, including increased mortality rates. These findings, therefore, indicate the need for more robust standardized surveillance to confirm the patterns observed. Increasing resistance towards amoxiclav implies narrowed treatment options for diarrhoea, posing a public health threat.